The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2021
DOI: 10.1039/d0nr08116g
|View full text |Cite
|
Sign up to set email alerts
|

Self-sustaining enzyme nanocapsules perform on-site chemical reactions

Abstract: Nanoreactors offer a great platform for the onsite generation of functional products. However, the production of the desired compound is often limited by either the availability of the reagents or...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0
4

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 12 publications
(19 citation statements)
references
References 48 publications
(53 reference statements)
0
15
0
4
Order By: Relevance
“…Controlled release of plasmidDNA 66 Absence of chemical modification of the drug Limited encapsulation efficiencies Targeted delivery of siRNA 67 Variety of morphologies and architectures High risk of dissociation in blood mRNA delivery (animal study) 68 High protection Polymersome delivery of the SARS-CoV-2 spike protein (preclinical trials) 69 Nanoparticle/ nanogel/ nanocapsule Physical encapsulation Protein encapsulation 70 Absence of chemical modification of the drug Risk of denaturation due to crosslinking reactions involved Enzyme nanocapsules 71 High protection Delivery and controlled release of deoxyribonuclease I 72 High stability Vaccine development based on nanogel protein delivery (animal study) 73 Easy incorporation of smart units Iduronate 2-sulfatase delivery with PLGA nanoparticles (preclinical testing) 74 Controlled release harness the immune stimulatory benefits of the protein to increase the anti-tumor responses while minimizing undesired therapeutical side effects. 84 In this PEG-functionalized form, the IL2 is inactive and a biological prodrug.…”
Section: Physical Encapsulationmentioning
confidence: 99%
See 4 more Smart Citations
“…Controlled release of plasmidDNA 66 Absence of chemical modification of the drug Limited encapsulation efficiencies Targeted delivery of siRNA 67 Variety of morphologies and architectures High risk of dissociation in blood mRNA delivery (animal study) 68 High protection Polymersome delivery of the SARS-CoV-2 spike protein (preclinical trials) 69 Nanoparticle/ nanogel/ nanocapsule Physical encapsulation Protein encapsulation 70 Absence of chemical modification of the drug Risk of denaturation due to crosslinking reactions involved Enzyme nanocapsules 71 High protection Delivery and controlled release of deoxyribonuclease I 72 High stability Vaccine development based on nanogel protein delivery (animal study) 73 Easy incorporation of smart units Iduronate 2-sulfatase delivery with PLGA nanoparticles (preclinical testing) 74 Controlled release harness the immune stimulatory benefits of the protein to increase the anti-tumor responses while minimizing undesired therapeutical side effects. 84 In this PEG-functionalized form, the IL2 is inactive and a biological prodrug.…”
Section: Physical Encapsulationmentioning
confidence: 99%
“…For instance, such an approach allowed for the encapsulation of multiple enzymes in one nanocapsule with the aim of performing enzymatic cascade reactions. 71 Similar strategies have been used to prepare both polymer and silica nanocapsules. 71,161 All of the enzymes involved maintained their enzymatic activity after the encapsulation while they were successfully protected against proteases and heat.…”
Section: Nanoparticles Nanogels and Nanocapsulesmentioning
confidence: 99%
See 3 more Smart Citations